Literature DB >> 14990672

Validation of a multiwell gamma-counter for measuring high-pressure liquid chromatography metabolite profiles.

Henri N J M Greuter1, Patricia L B van Ophemert, Gert Luurtsema, Eric J F Franssen, Ronald Boellaard, Adriaan A Lammertsma.   

Abstract

OBJECTIVES: The purpose of this study was to verify the accuracy and reproducibility of a multiwell counter to assess its suitability for use within human PET studies in which metabolizing (11)C tracers are used. Such tracers often require metabolite analysis for deriving plasma metabolite-corrected input curves. High-pressure liquid chromatography (HPLC) with on-line activity measurement is often unreliable for later plasma samples due to the poor sensitivity of the on-line activity detector. Fraction collector obtained HPLC samples that are counted in a separate high-sensitivity well counter can be an alternative to overcome poor counting statistics.
METHODS: Several experiments to evaluate background counting, reproducibility, and linearity were performed to validate the accuracy, precision, and detection limits of the well counter. In addition, measurements on a series of samples resembling activity profiles as seen within human (11)C-flumazenil studies were performed to evaluate the performance of the well counter for clinically relevant data.
RESULTS: The tests proved that the well counter detection limit, linearity, and reproducibility were more than sufficient in circumstances as seen during patient studies for samples with both high and low activity.
CONCLUSION: The use of a multiwell counter is a good alternative for the on-line activity detector of the HPLC, allowing derivation of plasma metabolite fractions with high accuracy and reproducibility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990672

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  3 in total

1.  Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations.

Authors:  Catharina M van Rij; Alwin D R Huitema; Eleonora L Swart; Henricus N J M Greuter; Adriaan A Lammertsma; Arie C van Loenen; Eric J F Franssen
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

2.  Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies.

Authors:  Maqsood Yaqub; Ronald Boellaard; Bart N M van Berckel; Nelleke Tolboom; Gert Luurtsema; Anke A Dijkstra; Mark Lubberink; Albert D Windhorst; Philip Scheltens; Adriaan A Lammertsma
Journal:  Mol Imaging Biol       Date:  2009-04-02       Impact factor: 3.488

3.  Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [11C]DPA-713 Positron Emission Tomography.

Authors:  Maqsood Yaqub; Nicki J F Verweij; Simone Pieplenbosch; Ronald Boellaard; Adriaan A Lammertsma; Conny J van der Laken
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.